ERN1 and metastatic malignant neoplasm: During metastasis, the IRE1α-XBP1 pathway interacts with HIF1α (Hypoxia-inducible factor 1-alpha) to promote tumor growth and survival in hypoxia, making it a potential target for treating metastatic cancer [35].